Targeted Knock-In Mice Expressing Mutations of CD28 Reveal an Essential Pathway for Costimulation

REFERENCES

• Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. Gaffney, C. B. Reese, and P. Cohen. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7:261–269.
   PubMed Web of Science ®Google Scholar
• Ali, A., K. P. Hoeflich, and J. R. Woodgett. 2001. Glycogen synthase kinase-3: properties, functions, and regulation. Chem. Rev. 101:2527–2540.
   PubMedGoogle Scholar
• Andres, P. G., K. C. Howland, A. Nirula, L. P. Kane, L. Barron, D. Dresnek, A. Sadra, J. Imboden, A. Weiss, and A. K. Abbas. 2004. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nat. Immunol. 5:435–442.
   PubMed Web of Science ®Google Scholar
• Appleman, L. J., A. A. van Puijenbroek, K. M. Shu, L. M. Nadler, and V. A. Boussiotis. 2002. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168:2729–2736.
   PubMed Web of Science ®Google Scholar
• Ballou, L. M., P.-Y. Tian, H.-Y. Lin, Y.-P. Jiang, and R. Z. Lin. 2001. Dual regulation of glycogen synthase kinase-3β by the α1A-adrenergic receptor. J. Biol. Chem. 276:40910–40916.
   PubMed Web of Science ®Google Scholar
• Bauer, B., N. Krumbock, F. Fresser, F. Hochholdinger, M. Spitaler, A. Simm, F. Uberall, B. Schraven, and G. Baier. 2001. Complex formation and cooperation of protein kinase Cθ and Akt1/protein kinase Bα in the NF-kappa B transactivation cascade in Jurkat T cells. J. Biol. Chem. 276:31627–31634.
   PubMed Web of Science ®Google Scholar
• Bayascas, J. R., and D. R. Alessi. 2005. Regulation of Akt/PKB Ser473 phosphorylation. Mol. Cell 18:143–145.
   PubMedGoogle Scholar
• Bi, K., Y. Tanaka, N. Coudronniere, K. Sugie, S. Hong, M. J. van Stipdonk, and A. Altman. 2001. Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat. Immunol. 2:556–563.
   PubMed Web of Science ®Google Scholar
• Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87–98.
   PubMed Web of Science ®Google Scholar
• Burr, J. S., S. L. Kimzey, D. R. Randolph, and J. M. Green. 2001. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am. J. Respir. Cell. Mol. Biol. 24:563–568.
   PubMed Web of Science ®Google Scholar
• Burr, J. S., N. D. L. Savage, G. E. Messah, S. L. Kimzey, A. S. Shaw, R. H. Arch., and J. M. Green. 2001. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J. Immunol. 166:5331–5335.
   PubMedGoogle Scholar
• Cai, Y. C., D. Cefai, H. Schneider, M. Raab, N. Nabavi, and C. E. Rudd. 1995. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 3:417–426.
   PubMedGoogle Scholar
• Chang, T. T., C. Jabs, R. A. Sobel, V. K. Kuchroo, and A. H. Sharpe. 1999. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J. Exp. Med. 190:733–740.
   PubMed Web of Science ®Google Scholar
• Chen, R., O. Kim, J. Yang, K. Sato, K. M. Eisenmann, J. McCarthy, H. Chen, and Y. Qiu. 2001. Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276:31858–31862.
   PubMedGoogle Scholar
• Diehn, M., A. A. Alizadeh, O. J. Rando, C. L. Liu, K. Stankunas, D. Botstein, G. R. Crabtree, and P. O. Brown. 2002. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 99:11796–11801.
   PubMed Web of Science ®Google Scholar
• Dittel, B. N. 2008. CD4 T cells: balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain Behav. Immun. 22:421–430.
   PubMedGoogle Scholar
• Dutil, E. M., A. Toker, and A. C. Newton. 1998. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8:1366–1375.
   PubMed Web of Science ®Google Scholar
• Fang, X., S. Yu, J. L. Tanyi, Y. Lu, J. R. Woodgett, and G. B. Mills. 2002. Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway. Mol. Cell. Biol. 22:2099–2110.
   PubMed Web of Science ®Google Scholar
• Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313–316.
   PubMed Web of Science ®Google Scholar
• Friend, L. D., D. D. Shah, C. Deppong, J. Lin, T. L. Bricker, T. I. Juehne, C. M. Rose, and J. M. Green. 2006. A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant. J. Exp. Med. 203:2121–2133.
   PubMedGoogle Scholar
• Genovese, M. C., J. C. Becker, M. Schiff, M. Luggen, Y. Sherrer, J. Kremer, C. Birbara, J. Box, K. Natarajan, I. Nuamah, T. Li, R. Aranda, D. T. Hagerty, and M. Dougados. 2005. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N. Engl. J. Med. 353:1114–1123.
   PubMed Web of Science ®Google Scholar
• Gold, R., C. Linington, and H. Lassmann. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953–1971.
   PubMed Web of Science ®Google Scholar
• Goode, N., K. Hughes, J. R. Woodgett, and P. J. Parker. 1992. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J. Biol. Chem. 267:16878–16882.
   PubMed Web of Science ®Google Scholar
• Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501–508.
   PubMed Web of Science ®Google Scholar
• Harada, Y., M. Tokushima, Y. Matsumoto, S. Ogawa, M. Otsuka, K. Hayashi, B. D. Weiss, C. H. June, and R. Abe. 2001. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J. Immunol. 166:3797–3803.
   PubMedGoogle Scholar
• Hayashi, K., and A. Altman. 2007. Protein kinase C theta (PKCθ): a key player in T cell life and death. Pharmacol. Res. 55:537–544.
   PubMed Web of Science ®Google Scholar
• Holdorf, A. D., J. M. Green, S. D. Levin, M. F. Denny, D. B. Straus, V. Link, P. S. Changelian, P. M. Allen, and A. S. Shaw. 1999. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190:375–384.
   PubMed Web of Science ®Google Scholar
• Hutchcroft, J. E., and B. E. Bierer. 1996. Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. J. Immunol. 156:4071–4074.
   PubMedGoogle Scholar
• Jones, R. G., M. Parsons, M. Bonnard, V. S. Chan, W. C. Yeh, J. R. Woodgett, and P. S. Ohashi. 2000. Protein kinase B regulates T lymphocyte survival, nuclear factor κB activation, and Bcl-XL levels in vivo. J. Exp. Med. 191:1721–1734.
   PubMedGoogle Scholar
• June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472–4481.
   PubMed Web of Science ®Google Scholar
• Kane, L. P., P. G. Andres, K. C. Howland, A. K. Abbas, and A. Weiss. 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat. Immunol. 2:37–44.
   PubMed Web of Science ®Google Scholar
• Keir, M. E., and A. H. Sharpe. 2005. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 204:128–143.
   PubMed Web of Science ®Google Scholar
• Kim, H.-H., M. Tharayil, and C. E. Rudd. 1998. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 273:296–301.
   PubMedGoogle Scholar
• Kimzey, S. L., P. Liu, and J. M. Green. 2004. Requirement for CD28 in the effector phase of allergic airway inflammation. J. Immunol. 173:632–640.
   PubMedGoogle Scholar
• Kung, T. T., H. Jones, G. K. Adams III, S. P. Umland, W. Kreutner, R. W. Egan, R. W. Chapman, and A. S. Watnick. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy. Immunol. 105:83–90.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. E. Sedwick, J. Hu, and A. Altman. 2005. Role for protein kinase Cθ (PKCθ) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-κB activation. J. Biol. Chem. 280:1217–1223.
   PubMedGoogle Scholar
• Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339–343.
   PubMed Web of Science ®Google Scholar
• Liu, Y., S. Witte, Y. C. Liu, M. Doyle, C. Elly, and A. Altman. 2000. Regulation of protein kinase Cθ function during T cell activation by Lck-mediated tyrosine phosphorylation. J. Biol. Chem. 275:3603–3609.
   PubMed Web of Science ®Google Scholar
• Manicassamy, S., S. Gupta, Z. Huang, and Z. Sun. 2006. Protein kinase Cθ-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL. J. Immunol. 176:6709–6716.
   PubMedGoogle Scholar
• Nirula, A., M. Ho, H. Phee, J. Roose, and A. Weiss. 2006. Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4. J. Exp. Med. 203:1733–1744.
   PubMedGoogle Scholar
• Ohteki, T., M. Parsons, A. Zakarian, R. G. Jones, L. T. Nguyen, J. R. Woodgett, and P. S. Ohashi. 2000. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J. Exp. Med. 192:99–104.
   PubMed Web of Science ®Google Scholar
• Okkenhaug, K., and R. Rottapel. 1998. Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. J. Biol. Chem. 273:21194–21202.
   PubMed Web of Science ®Google Scholar
• Okkenhaug, K., L. Wu, K. M. Garza, J. La Rose, W. Khoo, B. Odermatt, T. W. Mak, P. S. Ohashi, and R. Rottapel. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2:325–332.
   PubMed Web of Science ®Google Scholar
• Pagès, F., M. Ragueneau, S. Klasen, M. Battifora, D. Couez, R. Sweet, A. Truneh, S. G. Ward, and D. Olive. 1996. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J. Biol. Chem. 271:9403–9409.
   PubMedGoogle Scholar
• Park, J., M. M. Hill, D. Hess, D. P. Brazil, J. Hofsteenge, and B. A. Hemmings. 2001. Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity. J. Biol. Chem. 276:37459–37471.
   PubMedGoogle Scholar
• Parry, R. V., K. Reif, G. Smith, D. M. Sansom, B. A. Hemmings, and S. G. Ward. 1997. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol. 27:2495–2501.
   PubMedGoogle Scholar
• Pfeifhofer, C., K. Kofler, T. Gruber, N. G. Tabrizi, C. Lutz, K. Maly, M. Leitges, and G. Baier. 2003. Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197:1525–1535.
   PubMed Web of Science ®Google Scholar
• Raab, M., Y. C. Cai, S. C. Bunnell, S. D. Heyeck, L. J. Berg, and C. E. Rudd. 1995. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3- kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl. Acad. Sci. USA 92:8891–8895.
   PubMedGoogle Scholar
• Sanchez-Lockhart, M., E. Marin, B. Graf, R. Abe, Y. Harada, C. E. Sedwick, and J. Miller. 2004. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J. Immunol. 173:7120–7124.
   PubMedGoogle Scholar
• Sedwick, C. E., and A. Altman. 2004. Perspectives on PKCθ in T cell activation. Mol. Immunol. 41:675–686.
   PubMedGoogle Scholar
• Stein, P. H., J. D. Fraser, and A. Weiss. 1994. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 14:3392–3402.
   PubMedGoogle Scholar
• Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-theta is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404:402–407.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333–1337.
   PubMed Web of Science ®Google Scholar
• Toker, A., and A. C. Newton. 2000. Cellular signaling: pivoting around PDK-1. Cell 103:185–188.
   PubMed Web of Science ®Google Scholar
• van Weeren, P. C., K. M. de Bruyn, A. M. de Vries-Smits, J. van Lint, and B. M. Burgering. 1998. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273:13150–13156.
   PubMed Web of Science ®Google Scholar
• Vilimek, D., and V. Duronio. 2006. Cytokine-stimulated phosphorylation of GSK-3 is primarily dependent upon PKCs, not PKB. Biochem. Cell. Biol. 84:20–29.
   PubMedGoogle Scholar
• Vincenti, F., C. Larsen, A. Durrbach, T. Wekerle, B. Nashan, G. Blancho, P. Lang, J. Grinyo, P. F. Halloran, K. Solez, D. Hagerty, E. Levy, W. Zhou, K. Natarajan, and B. Charpentier. 2005. Costimulation blockade with belatacept in renal transplantation. N. Engl. J. Med. 353:770–781.
   PubMed Web of Science ®Google Scholar
• Wood, J. E., H. Schneider, and C. E. Rudd. 2006. TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1. J. Biol. Chem. 281:32385–32394.
   PubMedGoogle Scholar